[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
January 1, 1997

Collaboration Needed for HIV Vaccine Success

JAMA. 1997;277(1):9. doi:10.1001/jama.1997.03540250017009

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


A MUCH STRONGER public-private partnership is needed if a safe, effective vaccine against the human immunodeficiency virus (HIV) is going to be developed, says a new report entitled Industry Investment in HIV Vaccine Research.

The AIDS Vaccine Advocacy Coalition (AVAC) in San Francisco, Calif, which released the report on World AIDS Day, says working relationships between government and industry have improved in recent years, but many deficits remain. In fact, the report's authors call government leadership the "key ingredient" needed to expedite the creation of a successful vaccine.

"We were surprised to learn that, in most cases, government is the engine that drives industry and that industry research depends on government financing, government leadership, and government support," said Chris Collins, MPP, an author of the report and policy specialist at the Center for AIDS Prevention Studies at the University of California at San Francisco.

Baltimore Appointment Hailed  About a week